Global Oligonucleotide Market Growth 2025-2031
The global Oligonucleotide market size is predicted to grow from US$ 1629 million in 2025 to US$ 2963 million in 2031; it is expected to grow at a CAGR of 10.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
LP Information, Inc. (LPI) ' newest research report, the ?Oligonucleotide Industry Forecast? looks at past sales and reviews total world Oligonucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide sales for 2025 through 2031. With Oligonucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oligonucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Oligonucleotide market?
What factors are driving Oligonucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide market opportunities vary by end market size?
How does Oligonucleotide break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
Oligonucleotide drugs have the advantages of high therapeutic efficiency, low drug toxicity, and strong specificity, and have great potential in the treatment of metabolic diseases, genetic diseases, cancer, and prevention of infectious diseases. In recent years, due to the unique advantages of oligonucleotides in regulating gene expression, the research and development, production and commercialization of their drugs have developed rapidly, and the global market has continued to expand.
LP Information, Inc. (LPI) ' newest research report, the ?Oligonucleotide Industry Forecast? looks at past sales and reviews total world Oligonucleotide sales in 2024, providing a comprehensive analysis by region and market sector of projected Oligonucleotide sales for 2025 through 2031. With Oligonucleotide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oligonucleotide industry.
This Insight Report provides a comprehensive analysis of the global Oligonucleotide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oligonucleotide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oligonucleotide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oligonucleotide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oligonucleotide.
This report presents a comprehensive overview, market shares, and growth opportunities of Oligonucleotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- DNA
- RNA
- Gene Chip
- Electrophoresis
- Fluorescence In Situ Hybridization
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Molecular
- PerkinElmer
- SciGene Corporation
- Roche NimbleGen
- CytoTest
- Oligo Factory
- Danaher
- Thermo Fisher Scientific
- GE
- Merck
- Eurofins Scientific
- Agilent
- SUMITOMO CHEMICAL
- Bachem
- Sylentis
What is the 10-year outlook for the global Oligonucleotide market?
What factors are driving Oligonucleotide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oligonucleotide market opportunities vary by end market size?
How does Oligonucleotide break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oligonucleotide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oligonucleotide by Country/Region, 2020, 2024 & 2031
2.2 Oligonucleotide Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Oligonucleotide Sales by Type
2.3.1 Global Oligonucleotide Sales Market Share by Type (2020-2025)
2.3.2 Global Oligonucleotide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oligonucleotide Sale Price by Type (2020-2025)
2.4 Oligonucleotide Segment by Application
2.4.1 Gene Chip
2.4.2 Electrophoresis
2.4.3 Fluorescence In Situ Hybridization
2.5 Oligonucleotide Sales by Application
2.5.1 Global Oligonucleotide Sale Market Share by Application (2020-2025)
2.5.2 Global Oligonucleotide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oligonucleotide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oligonucleotide Breakdown Data by Company
3.1.1 Global Oligonucleotide Annual Sales by Company (2020-2025)
3.1.2 Global Oligonucleotide Sales Market Share by Company (2020-2025)
3.2 Global Oligonucleotide Annual Revenue by Company (2020-2025)
3.2.1 Global Oligonucleotide Revenue by Company (2020-2025)
3.2.2 Global Oligonucleotide Revenue Market Share by Company (2020-2025)
3.3 Global Oligonucleotide Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Product Location Distribution
3.4.2 Players Oligonucleotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide Market Size by Geographic Region (2020-2025)
4.1.1 Global Oligonucleotide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oligonucleotide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oligonucleotide Market Size by Country/Region (2020-2025)
4.2.1 Global Oligonucleotide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oligonucleotide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide Sales Growth
4.4 APAC Oligonucleotide Sales Growth
4.5 Europe Oligonucleotide Sales Growth
4.6 Middle East & Africa Oligonucleotide Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide Sales by Country
5.1.1 Americas Oligonucleotide Sales by Country (2020-2025)
5.1.2 Americas Oligonucleotide Revenue by Country (2020-2025)
5.2 Americas Oligonucleotide Sales by Type (2020-2025)
5.3 Americas Oligonucleotide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Sales by Region
6.1.1 APAC Oligonucleotide Sales by Region (2020-2025)
6.1.2 APAC Oligonucleotide Revenue by Region (2020-2025)
6.2 APAC Oligonucleotide Sales by Type (2020-2025)
6.3 APAC Oligonucleotide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide by Country
7.1.1 Europe Oligonucleotide Sales by Country (2020-2025)
7.1.2 Europe Oligonucleotide Revenue by Country (2020-2025)
7.2 Europe Oligonucleotide Sales by Type (2020-2025)
7.3 Europe Oligonucleotide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide by Country
8.1.1 Middle East & Africa Oligonucleotide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oligonucleotide Revenue by Country (2020-2025)
8.2 Middle East & Africa Oligonucleotide Sales by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide
10.3 Manufacturing Process Analysis of Oligonucleotide
10.4 Industry Chain Structure of Oligonucleotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Distributors
11.3 Oligonucleotide Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide Market Size Forecast by Region
12.1.1 Global Oligonucleotide Forecast by Region (2026-2031)
12.1.2 Global Oligonucleotide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oligonucleotide Forecast by Type (2026-2031)
12.7 Global Oligonucleotide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Molecular
13.1.1 Abbott Molecular Company Information
13.1.2 Abbott Molecular Oligonucleotide Product Portfolios and Specifications
13.1.3 Abbott Molecular Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Molecular Main Business Overview
13.1.5 Abbott Molecular Latest Developments
13.2 PerkinElmer
13.2.1 PerkinElmer Company Information
13.2.2 PerkinElmer Oligonucleotide Product Portfolios and Specifications
13.2.3 PerkinElmer Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 PerkinElmer Main Business Overview
13.2.5 PerkinElmer Latest Developments
13.3 SciGene Corporation
13.3.1 SciGene Corporation Company Information
13.3.2 SciGene Corporation Oligonucleotide Product Portfolios and Specifications
13.3.3 SciGene Corporation Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SciGene Corporation Main Business Overview
13.3.5 SciGene Corporation Latest Developments
13.4 Roche NimbleGen
13.4.1 Roche NimbleGen Company Information
13.4.2 Roche NimbleGen Oligonucleotide Product Portfolios and Specifications
13.4.3 Roche NimbleGen Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche NimbleGen Main Business Overview
13.4.5 Roche NimbleGen Latest Developments
13.5 CytoTest
13.5.1 CytoTest Company Information
13.5.2 CytoTest Oligonucleotide Product Portfolios and Specifications
13.5.3 CytoTest Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CytoTest Main Business Overview
13.5.5 CytoTest Latest Developments
13.6 Oligo Factory
13.6.1 Oligo Factory Company Information
13.6.2 Oligo Factory Oligonucleotide Product Portfolios and Specifications
13.6.3 Oligo Factory Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Oligo Factory Main Business Overview
13.6.5 Oligo Factory Latest Developments
13.7 Danaher
13.7.1 Danaher Company Information
13.7.2 Danaher Oligonucleotide Product Portfolios and Specifications
13.7.3 Danaher Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Danaher Main Business Overview
13.7.5 Danaher Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Oligonucleotide Product Portfolios and Specifications
13.8.3 Thermo Fisher Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 GE
13.9.1 GE Company Information
13.9.2 GE Oligonucleotide Product Portfolios and Specifications
13.9.3 GE Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GE Main Business Overview
13.9.5 GE Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck Oligonucleotide Product Portfolios and Specifications
13.10.3 Merck Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Eurofins Scientific
13.11.1 Eurofins Scientific Company Information
13.11.2 Eurofins Scientific Oligonucleotide Product Portfolios and Specifications
13.11.3 Eurofins Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Eurofins Scientific Main Business Overview
13.11.5 Eurofins Scientific Latest Developments
13.12 Agilent
13.12.1 Agilent Company Information
13.12.2 Agilent Oligonucleotide Product Portfolios and Specifications
13.12.3 Agilent Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agilent Main Business Overview
13.12.5 Agilent Latest Developments
13.13 SUMITOMO CHEMICAL
13.13.1 SUMITOMO CHEMICAL Company Information
13.13.2 SUMITOMO CHEMICAL Oligonucleotide Product Portfolios and Specifications
13.13.3 SUMITOMO CHEMICAL Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SUMITOMO CHEMICAL Main Business Overview
13.13.5 SUMITOMO CHEMICAL Latest Developments
13.14 Bachem
13.14.1 Bachem Company Information
13.14.2 Bachem Oligonucleotide Product Portfolios and Specifications
13.14.3 Bachem Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bachem Main Business Overview
13.14.5 Bachem Latest Developments
13.15 Sylentis
13.15.1 Sylentis Company Information
13.15.2 Sylentis Oligonucleotide Product Portfolios and Specifications
13.15.3 Sylentis Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sylentis Main Business Overview
13.15.5 Sylentis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oligonucleotide Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Oligonucleotide by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Oligonucleotide by Country/Region, 2020, 2024 & 2031
2.2 Oligonucleotide Segment by Type
2.2.1 DNA
2.2.2 RNA
2.3 Oligonucleotide Sales by Type
2.3.1 Global Oligonucleotide Sales Market Share by Type (2020-2025)
2.3.2 Global Oligonucleotide Revenue and Market Share by Type (2020-2025)
2.3.3 Global Oligonucleotide Sale Price by Type (2020-2025)
2.4 Oligonucleotide Segment by Application
2.4.1 Gene Chip
2.4.2 Electrophoresis
2.4.3 Fluorescence In Situ Hybridization
2.5 Oligonucleotide Sales by Application
2.5.1 Global Oligonucleotide Sale Market Share by Application (2020-2025)
2.5.2 Global Oligonucleotide Revenue and Market Share by Application (2020-2025)
2.5.3 Global Oligonucleotide Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Oligonucleotide Breakdown Data by Company
3.1.1 Global Oligonucleotide Annual Sales by Company (2020-2025)
3.1.2 Global Oligonucleotide Sales Market Share by Company (2020-2025)
3.2 Global Oligonucleotide Annual Revenue by Company (2020-2025)
3.2.1 Global Oligonucleotide Revenue by Company (2020-2025)
3.2.2 Global Oligonucleotide Revenue Market Share by Company (2020-2025)
3.3 Global Oligonucleotide Sale Price by Company
3.4 Key Manufacturers Oligonucleotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oligonucleotide Product Location Distribution
3.4.2 Players Oligonucleotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR OLIGONUCLEOTIDE BY GEOGRAPHIC REGION
4.1 World Historic Oligonucleotide Market Size by Geographic Region (2020-2025)
4.1.1 Global Oligonucleotide Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Oligonucleotide Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Oligonucleotide Market Size by Country/Region (2020-2025)
4.2.1 Global Oligonucleotide Annual Sales by Country/Region (2020-2025)
4.2.2 Global Oligonucleotide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Oligonucleotide Sales Growth
4.4 APAC Oligonucleotide Sales Growth
4.5 Europe Oligonucleotide Sales Growth
4.6 Middle East & Africa Oligonucleotide Sales Growth
5 AMERICAS
5.1 Americas Oligonucleotide Sales by Country
5.1.1 Americas Oligonucleotide Sales by Country (2020-2025)
5.1.2 Americas Oligonucleotide Revenue by Country (2020-2025)
5.2 Americas Oligonucleotide Sales by Type (2020-2025)
5.3 Americas Oligonucleotide Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oligonucleotide Sales by Region
6.1.1 APAC Oligonucleotide Sales by Region (2020-2025)
6.1.2 APAC Oligonucleotide Revenue by Region (2020-2025)
6.2 APAC Oligonucleotide Sales by Type (2020-2025)
6.3 APAC Oligonucleotide Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Oligonucleotide by Country
7.1.1 Europe Oligonucleotide Sales by Country (2020-2025)
7.1.2 Europe Oligonucleotide Revenue by Country (2020-2025)
7.2 Europe Oligonucleotide Sales by Type (2020-2025)
7.3 Europe Oligonucleotide Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oligonucleotide by Country
8.1.1 Middle East & Africa Oligonucleotide Sales by Country (2020-2025)
8.1.2 Middle East & Africa Oligonucleotide Revenue by Country (2020-2025)
8.2 Middle East & Africa Oligonucleotide Sales by Type (2020-2025)
8.3 Middle East & Africa Oligonucleotide Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oligonucleotide
10.3 Manufacturing Process Analysis of Oligonucleotide
10.4 Industry Chain Structure of Oligonucleotide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oligonucleotide Distributors
11.3 Oligonucleotide Customer
12 WORLD FORECAST REVIEW FOR OLIGONUCLEOTIDE BY GEOGRAPHIC REGION
12.1 Global Oligonucleotide Market Size Forecast by Region
12.1.1 Global Oligonucleotide Forecast by Region (2026-2031)
12.1.2 Global Oligonucleotide Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Oligonucleotide Forecast by Type (2026-2031)
12.7 Global Oligonucleotide Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Abbott Molecular
13.1.1 Abbott Molecular Company Information
13.1.2 Abbott Molecular Oligonucleotide Product Portfolios and Specifications
13.1.3 Abbott Molecular Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Abbott Molecular Main Business Overview
13.1.5 Abbott Molecular Latest Developments
13.2 PerkinElmer
13.2.1 PerkinElmer Company Information
13.2.2 PerkinElmer Oligonucleotide Product Portfolios and Specifications
13.2.3 PerkinElmer Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 PerkinElmer Main Business Overview
13.2.5 PerkinElmer Latest Developments
13.3 SciGene Corporation
13.3.1 SciGene Corporation Company Information
13.3.2 SciGene Corporation Oligonucleotide Product Portfolios and Specifications
13.3.3 SciGene Corporation Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 SciGene Corporation Main Business Overview
13.3.5 SciGene Corporation Latest Developments
13.4 Roche NimbleGen
13.4.1 Roche NimbleGen Company Information
13.4.2 Roche NimbleGen Oligonucleotide Product Portfolios and Specifications
13.4.3 Roche NimbleGen Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Roche NimbleGen Main Business Overview
13.4.5 Roche NimbleGen Latest Developments
13.5 CytoTest
13.5.1 CytoTest Company Information
13.5.2 CytoTest Oligonucleotide Product Portfolios and Specifications
13.5.3 CytoTest Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 CytoTest Main Business Overview
13.5.5 CytoTest Latest Developments
13.6 Oligo Factory
13.6.1 Oligo Factory Company Information
13.6.2 Oligo Factory Oligonucleotide Product Portfolios and Specifications
13.6.3 Oligo Factory Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Oligo Factory Main Business Overview
13.6.5 Oligo Factory Latest Developments
13.7 Danaher
13.7.1 Danaher Company Information
13.7.2 Danaher Oligonucleotide Product Portfolios and Specifications
13.7.3 Danaher Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Danaher Main Business Overview
13.7.5 Danaher Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Oligonucleotide Product Portfolios and Specifications
13.8.3 Thermo Fisher Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 GE
13.9.1 GE Company Information
13.9.2 GE Oligonucleotide Product Portfolios and Specifications
13.9.3 GE Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 GE Main Business Overview
13.9.5 GE Latest Developments
13.10 Merck
13.10.1 Merck Company Information
13.10.2 Merck Oligonucleotide Product Portfolios and Specifications
13.10.3 Merck Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Merck Main Business Overview
13.10.5 Merck Latest Developments
13.11 Eurofins Scientific
13.11.1 Eurofins Scientific Company Information
13.11.2 Eurofins Scientific Oligonucleotide Product Portfolios and Specifications
13.11.3 Eurofins Scientific Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Eurofins Scientific Main Business Overview
13.11.5 Eurofins Scientific Latest Developments
13.12 Agilent
13.12.1 Agilent Company Information
13.12.2 Agilent Oligonucleotide Product Portfolios and Specifications
13.12.3 Agilent Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Agilent Main Business Overview
13.12.5 Agilent Latest Developments
13.13 SUMITOMO CHEMICAL
13.13.1 SUMITOMO CHEMICAL Company Information
13.13.2 SUMITOMO CHEMICAL Oligonucleotide Product Portfolios and Specifications
13.13.3 SUMITOMO CHEMICAL Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 SUMITOMO CHEMICAL Main Business Overview
13.13.5 SUMITOMO CHEMICAL Latest Developments
13.14 Bachem
13.14.1 Bachem Company Information
13.14.2 Bachem Oligonucleotide Product Portfolios and Specifications
13.14.3 Bachem Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Bachem Main Business Overview
13.14.5 Bachem Latest Developments
13.15 Sylentis
13.15.1 Sylentis Company Information
13.15.2 Sylentis Oligonucleotide Product Portfolios and Specifications
13.15.3 Sylentis Oligonucleotide Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sylentis Main Business Overview
13.15.5 Sylentis Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oligonucleotide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oligonucleotide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of RNA
Table 5. Global Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 6. Global Oligonucleotide Sales Market Share by Type (2020-2025)
Table 7. Global Oligonucleotide Revenue by Type (2020-2025) & ($ million)
Table 8. Global Oligonucleotide Revenue Market Share by Type (2020-2025)
Table 9. Global Oligonucleotide Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Oligonucleotide Sale by Application (2020-2025) & (MT)
Table 11. Global Oligonucleotide Sale Market Share by Application (2020-2025)
Table 12. Global Oligonucleotide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Oligonucleotide Revenue Market Share by Application (2020-2025)
Table 14. Global Oligonucleotide Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Oligonucleotide Sales by Company (2020-2025) & (MT)
Table 16. Global Oligonucleotide Sales Market Share by Company (2020-2025)
Table 17. Global Oligonucleotide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Oligonucleotide Revenue Market Share by Company (2020-2025)
Table 19. Global Oligonucleotide Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Oligonucleotide Producing Area Distribution and Sales Area
Table 21. Players Oligonucleotide Products Offered
Table 22. Oligonucleotide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oligonucleotide Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Oligonucleotide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Oligonucleotide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Oligonucleotide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Oligonucleotide Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Oligonucleotide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Oligonucleotide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Oligonucleotide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 34. Americas Oligonucleotide Sales Market Share by Country (2020-2025)
Table 35. Americas Oligonucleotide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 37. Americas Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 38. APAC Oligonucleotide Sales by Region (2020-2025) & (MT)
Table 39. APAC Oligonucleotide Sales Market Share by Region (2020-2025)
Table 40. APAC Oligonucleotide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 42. APAC Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 43. Europe Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 44. Europe Oligonucleotide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 46. Europe Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Oligonucleotide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Oligonucleotide
Table 52. Key Market Challenges & Risks of Oligonucleotide
Table 53. Key Industry Trends of Oligonucleotide
Table 54. Oligonucleotide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oligonucleotide Distributors List
Table 57. Oligonucleotide Customer List
Table 58. Global Oligonucleotide Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Oligonucleotide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Oligonucleotide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Oligonucleotide Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Oligonucleotide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Oligonucleotide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Oligonucleotide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Oligonucleotide Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Oligonucleotide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Oligonucleotide Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Oligonucleotide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abbott Molecular Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Molecular Oligonucleotide Product Portfolios and Specifications
Table 74. Abbott Molecular Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Abbott Molecular Main Business
Table 76. Abbott Molecular Latest Developments
Table 77. PerkinElmer Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 78. PerkinElmer Oligonucleotide Product Portfolios and Specifications
Table 79. PerkinElmer Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. PerkinElmer Main Business
Table 81. PerkinElmer Latest Developments
Table 82. SciGene Corporation Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 83. SciGene Corporation Oligonucleotide Product Portfolios and Specifications
Table 84. SciGene Corporation Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. SciGene Corporation Main Business
Table 86. SciGene Corporation Latest Developments
Table 87. Roche NimbleGen Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche NimbleGen Oligonucleotide Product Portfolios and Specifications
Table 89. Roche NimbleGen Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Roche NimbleGen Main Business
Table 91. Roche NimbleGen Latest Developments
Table 92. CytoTest Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 93. CytoTest Oligonucleotide Product Portfolios and Specifications
Table 94. CytoTest Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. CytoTest Main Business
Table 96. CytoTest Latest Developments
Table 97. Oligo Factory Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 98. Oligo Factory Oligonucleotide Product Portfolios and Specifications
Table 99. Oligo Factory Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Oligo Factory Main Business
Table 101. Oligo Factory Latest Developments
Table 102. Danaher Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 103. Danaher Oligonucleotide Product Portfolios and Specifications
Table 104. Danaher Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Danaher Main Business
Table 106. Danaher Latest Developments
Table 107. Thermo Fisher Scientific Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 108. Thermo Fisher Scientific Oligonucleotide Product Portfolios and Specifications
Table 109. Thermo Fisher Scientific Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Thermo Fisher Scientific Main Business
Table 111. Thermo Fisher Scientific Latest Developments
Table 112. GE Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 113. GE Oligonucleotide Product Portfolios and Specifications
Table 114. GE Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. GE Main Business
Table 116. GE Latest Developments
Table 117. Merck Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Oligonucleotide Product Portfolios and Specifications
Table 119. Merck Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Eurofins Scientific Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 123. Eurofins Scientific Oligonucleotide Product Portfolios and Specifications
Table 124. Eurofins Scientific Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Eurofins Scientific Main Business
Table 126. Eurofins Scientific Latest Developments
Table 127. Agilent Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 128. Agilent Oligonucleotide Product Portfolios and Specifications
Table 129. Agilent Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. Agilent Main Business
Table 131. Agilent Latest Developments
Table 132. SUMITOMO CHEMICAL Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 133. SUMITOMO CHEMICAL Oligonucleotide Product Portfolios and Specifications
Table 134. SUMITOMO CHEMICAL Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. SUMITOMO CHEMICAL Main Business
Table 136. SUMITOMO CHEMICAL Latest Developments
Table 137. Bachem Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 138. Bachem Oligonucleotide Product Portfolios and Specifications
Table 139. Bachem Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 140. Bachem Main Business
Table 141. Bachem Latest Developments
Table 142. Sylentis Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 143. Sylentis Oligonucleotide Product Portfolios and Specifications
Table 144. Sylentis Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 145. Sylentis Main Business
Table 146. Sylentis Latest Developments
Table 1. Oligonucleotide Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Oligonucleotide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of RNA
Table 5. Global Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 6. Global Oligonucleotide Sales Market Share by Type (2020-2025)
Table 7. Global Oligonucleotide Revenue by Type (2020-2025) & ($ million)
Table 8. Global Oligonucleotide Revenue Market Share by Type (2020-2025)
Table 9. Global Oligonucleotide Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Oligonucleotide Sale by Application (2020-2025) & (MT)
Table 11. Global Oligonucleotide Sale Market Share by Application (2020-2025)
Table 12. Global Oligonucleotide Revenue by Application (2020-2025) & ($ million)
Table 13. Global Oligonucleotide Revenue Market Share by Application (2020-2025)
Table 14. Global Oligonucleotide Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Oligonucleotide Sales by Company (2020-2025) & (MT)
Table 16. Global Oligonucleotide Sales Market Share by Company (2020-2025)
Table 17. Global Oligonucleotide Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Oligonucleotide Revenue Market Share by Company (2020-2025)
Table 19. Global Oligonucleotide Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Oligonucleotide Producing Area Distribution and Sales Area
Table 21. Players Oligonucleotide Products Offered
Table 22. Oligonucleotide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Oligonucleotide Sales by Geographic Region (2020-2025) & (MT)
Table 26. Global Oligonucleotide Sales Market Share Geographic Region (2020-2025)
Table 27. Global Oligonucleotide Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Oligonucleotide Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Oligonucleotide Sales by Country/Region (2020-2025) & (MT)
Table 30. Global Oligonucleotide Sales Market Share by Country/Region (2020-2025)
Table 31. Global Oligonucleotide Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Oligonucleotide Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 34. Americas Oligonucleotide Sales Market Share by Country (2020-2025)
Table 35. Americas Oligonucleotide Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 37. Americas Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 38. APAC Oligonucleotide Sales by Region (2020-2025) & (MT)
Table 39. APAC Oligonucleotide Sales Market Share by Region (2020-2025)
Table 40. APAC Oligonucleotide Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 42. APAC Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 43. Europe Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 44. Europe Oligonucleotide Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 46. Europe Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 47. Middle East & Africa Oligonucleotide Sales by Country (2020-2025) & (MT)
Table 48. Middle East & Africa Oligonucleotide Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Oligonucleotide Sales by Type (2020-2025) & (MT)
Table 50. Middle East & Africa Oligonucleotide Sales by Application (2020-2025) & (MT)
Table 51. Key Market Drivers & Growth Opportunities of Oligonucleotide
Table 52. Key Market Challenges & Risks of Oligonucleotide
Table 53. Key Industry Trends of Oligonucleotide
Table 54. Oligonucleotide Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Oligonucleotide Distributors List
Table 57. Oligonucleotide Customer List
Table 58. Global Oligonucleotide Sales Forecast by Region (2026-2031) & (MT)
Table 59. Global Oligonucleotide Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 61. Americas Oligonucleotide Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Oligonucleotide Sales Forecast by Region (2026-2031) & (MT)
Table 63. APAC Oligonucleotide Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 65. Europe Oligonucleotide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Oligonucleotide Sales Forecast by Country (2026-2031) & (MT)
Table 67. Middle East & Africa Oligonucleotide Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Oligonucleotide Sales Forecast by Type (2026-2031) & (MT)
Table 69. Global Oligonucleotide Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Oligonucleotide Sales Forecast by Application (2026-2031) & (MT)
Table 71. Global Oligonucleotide Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Abbott Molecular Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 73. Abbott Molecular Oligonucleotide Product Portfolios and Specifications
Table 74. Abbott Molecular Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Abbott Molecular Main Business
Table 76. Abbott Molecular Latest Developments
Table 77. PerkinElmer Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 78. PerkinElmer Oligonucleotide Product Portfolios and Specifications
Table 79. PerkinElmer Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. PerkinElmer Main Business
Table 81. PerkinElmer Latest Developments
Table 82. SciGene Corporation Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 83. SciGene Corporation Oligonucleotide Product Portfolios and Specifications
Table 84. SciGene Corporation Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. SciGene Corporation Main Business
Table 86. SciGene Corporation Latest Developments
Table 87. Roche NimbleGen Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 88. Roche NimbleGen Oligonucleotide Product Portfolios and Specifications
Table 89. Roche NimbleGen Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Roche NimbleGen Main Business
Table 91. Roche NimbleGen Latest Developments
Table 92. CytoTest Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 93. CytoTest Oligonucleotide Product Portfolios and Specifications
Table 94. CytoTest Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. CytoTest Main Business
Table 96. CytoTest Latest Developments
Table 97. Oligo Factory Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 98. Oligo Factory Oligonucleotide Product Portfolios and Specifications
Table 99. Oligo Factory Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Oligo Factory Main Business
Table 101. Oligo Factory Latest Developments
Table 102. Danaher Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 103. Danaher Oligonucleotide Product Portfolios and Specifications
Table 104. Danaher Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Danaher Main Business
Table 106. Danaher Latest Developments
Table 107. Thermo Fisher Scientific Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 108. Thermo Fisher Scientific Oligonucleotide Product Portfolios and Specifications
Table 109. Thermo Fisher Scientific Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Thermo Fisher Scientific Main Business
Table 111. Thermo Fisher Scientific Latest Developments
Table 112. GE Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 113. GE Oligonucleotide Product Portfolios and Specifications
Table 114. GE Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. GE Main Business
Table 116. GE Latest Developments
Table 117. Merck Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Oligonucleotide Product Portfolios and Specifications
Table 119. Merck Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Eurofins Scientific Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 123. Eurofins Scientific Oligonucleotide Product Portfolios and Specifications
Table 124. Eurofins Scientific Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Eurofins Scientific Main Business
Table 126. Eurofins Scientific Latest Developments
Table 127. Agilent Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 128. Agilent Oligonucleotide Product Portfolios and Specifications
Table 129. Agilent Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 130. Agilent Main Business
Table 131. Agilent Latest Developments
Table 132. SUMITOMO CHEMICAL Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 133. SUMITOMO CHEMICAL Oligonucleotide Product Portfolios and Specifications
Table 134. SUMITOMO CHEMICAL Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 135. SUMITOMO CHEMICAL Main Business
Table 136. SUMITOMO CHEMICAL Latest Developments
Table 137. Bachem Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 138. Bachem Oligonucleotide Product Portfolios and Specifications
Table 139. Bachem Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 140. Bachem Main Business
Table 141. Bachem Latest Developments
Table 142. Sylentis Basic Information, Oligonucleotide Manufacturing Base, Sales Area and Its Competitors
Table 143. Sylentis Oligonucleotide Product Portfolios and Specifications
Table 144. Sylentis Oligonucleotide Sales (MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 145. Sylentis Main Business
Table 146. Sylentis Latest Developments
LIST OF FIGURES
Figure 1. Picture of Oligonucleotide
Figure 2. Oligonucleotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Oligonucleotide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oligonucleotide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oligonucleotide Sales Market Share by Country/Region (2024)
Figure 10. Oligonucleotide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of DNA
Figure 12. Product Picture of RNA
Figure 13. Global Oligonucleotide Sales Market Share by Type in 2025
Figure 14. Global Oligonucleotide Revenue Market Share by Type (2020-2025)
Figure 15. Oligonucleotide Consumed in Gene Chip
Figure 16. Global Oligonucleotide Market: Gene Chip (2020-2025) & (MT)
Figure 17. Oligonucleotide Consumed in Electrophoresis
Figure 18. Global Oligonucleotide Market: Electrophoresis (2020-2025) & (MT)
Figure 19. Oligonucleotide Consumed in Fluorescence In Situ Hybridization
Figure 20. Global Oligonucleotide Market: Fluorescence In Situ Hybridization (2020-2025) & (MT)
Figure 21. Global Oligonucleotide Sale Market Share by Application (2024)
Figure 22. Global Oligonucleotide Revenue Market Share by Application in 2025
Figure 23. Oligonucleotide Sales by Company in 2025 (MT)
Figure 24. Global Oligonucleotide Sales Market Share by Company in 2025
Figure 25. Oligonucleotide Revenue by Company in 2025 ($ millions)
Figure 26. Global Oligonucleotide Revenue Market Share by Company in 2025
Figure 27. Global Oligonucleotide Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Oligonucleotide Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Oligonucleotide Sales 2020-2025 (MT)
Figure 30. Americas Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 31. APAC Oligonucleotide Sales 2020-2025 (MT)
Figure 32. APAC Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 33. Europe Oligonucleotide Sales 2020-2025 (MT)
Figure 34. Europe Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Oligonucleotide Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 37. Americas Oligonucleotide Sales Market Share by Country in 2025
Figure 38. Americas Oligonucleotide Revenue Market Share by Country (2020-2025)
Figure 39. Americas Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 40. Americas Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 41. United States Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Oligonucleotide Sales Market Share by Region in 2025
Figure 46. APAC Oligonucleotide Revenue Market Share by Region (2020-2025)
Figure 47. APAC Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 48. APAC Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 49. China Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 53. India Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Oligonucleotide Sales Market Share by Country in 2025
Figure 57. Europe Oligonucleotide Revenue Market Share by Country (2020-2025)
Figure 58. Europe Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 59. Europe Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 60. Germany Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 61. France Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Oligonucleotide Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 68. Egypt Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Oligonucleotide in 2025
Figure 74. Manufacturing Process Analysis of Oligonucleotide
Figure 75. Industry Chain Structure of Oligonucleotide
Figure 76. Channels of Distribution
Figure 77. Global Oligonucleotide Sales Market Forecast by Region (2026-2031)
Figure 78. Global Oligonucleotide Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Oligonucleotide Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Oligonucleotide Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Oligonucleotide Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Oligonucleotide Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Oligonucleotide
Figure 2. Oligonucleotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oligonucleotide Sales Growth Rate 2020-2031 (MT)
Figure 7. Global Oligonucleotide Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Oligonucleotide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Oligonucleotide Sales Market Share by Country/Region (2024)
Figure 10. Oligonucleotide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of DNA
Figure 12. Product Picture of RNA
Figure 13. Global Oligonucleotide Sales Market Share by Type in 2025
Figure 14. Global Oligonucleotide Revenue Market Share by Type (2020-2025)
Figure 15. Oligonucleotide Consumed in Gene Chip
Figure 16. Global Oligonucleotide Market: Gene Chip (2020-2025) & (MT)
Figure 17. Oligonucleotide Consumed in Electrophoresis
Figure 18. Global Oligonucleotide Market: Electrophoresis (2020-2025) & (MT)
Figure 19. Oligonucleotide Consumed in Fluorescence In Situ Hybridization
Figure 20. Global Oligonucleotide Market: Fluorescence In Situ Hybridization (2020-2025) & (MT)
Figure 21. Global Oligonucleotide Sale Market Share by Application (2024)
Figure 22. Global Oligonucleotide Revenue Market Share by Application in 2025
Figure 23. Oligonucleotide Sales by Company in 2025 (MT)
Figure 24. Global Oligonucleotide Sales Market Share by Company in 2025
Figure 25. Oligonucleotide Revenue by Company in 2025 ($ millions)
Figure 26. Global Oligonucleotide Revenue Market Share by Company in 2025
Figure 27. Global Oligonucleotide Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Oligonucleotide Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Oligonucleotide Sales 2020-2025 (MT)
Figure 30. Americas Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 31. APAC Oligonucleotide Sales 2020-2025 (MT)
Figure 32. APAC Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 33. Europe Oligonucleotide Sales 2020-2025 (MT)
Figure 34. Europe Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Oligonucleotide Sales 2020-2025 (MT)
Figure 36. Middle East & Africa Oligonucleotide Revenue 2020-2025 ($ millions)
Figure 37. Americas Oligonucleotide Sales Market Share by Country in 2025
Figure 38. Americas Oligonucleotide Revenue Market Share by Country (2020-2025)
Figure 39. Americas Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 40. Americas Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 41. United States Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Oligonucleotide Sales Market Share by Region in 2025
Figure 46. APAC Oligonucleotide Revenue Market Share by Region (2020-2025)
Figure 47. APAC Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 48. APAC Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 49. China Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 53. India Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Oligonucleotide Sales Market Share by Country in 2025
Figure 57. Europe Oligonucleotide Revenue Market Share by Country (2020-2025)
Figure 58. Europe Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 59. Europe Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 60. Germany Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 61. France Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Oligonucleotide Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Oligonucleotide Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Oligonucleotide Sales Market Share by Application (2020-2025)
Figure 68. Egypt Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Oligonucleotide Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Oligonucleotide in 2025
Figure 74. Manufacturing Process Analysis of Oligonucleotide
Figure 75. Industry Chain Structure of Oligonucleotide
Figure 76. Channels of Distribution
Figure 77. Global Oligonucleotide Sales Market Forecast by Region (2026-2031)
Figure 78. Global Oligonucleotide Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Oligonucleotide Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Oligonucleotide Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Oligonucleotide Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Oligonucleotide Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Magnesite Market Growth 2025-2031
US$ 3,660.00
January 2025
117 pages
Global Oxygen Scavenger Additive Masterbatch Market Growth 2023-2029
US$ 3,660.00
February 2023
95 pages
Global 2-Amino-4,6-Dimethoxypyrimidine Market Growth 2025-2031
US$ 3,660.00
December 2025
118 pages
Global Nonyl Acetate Market Growth 2024-2030
US$ 3,660.00
September 2024
80 pages
